Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: A role for transforming growth factor beta

Liver

Volumn 17, Issue 3, 1997, Pages 152-156

  Orsatti, Giulia ^a,b   Hytiroglou, Prodromos ^a,b   Thung, Swan N ^b   Ishak, Kamal G ^c   Paronetto, Fiorenzo ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Cancer; Carcinoma; Fibrolamellar carcinoma; Fibrosis growth factor; Hepatocellular carcinoma; Hepatoma; Immunohistochemistry; Liver; TGF

Indexed keywords

PARAFFIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CLINICAL ARTICLE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER PARENCHYMA; PROTEIN EXPRESSION; STAINING;

EID: 0030762644     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb00798.x     Document Type: Article

References (27)

1. ROBERTS A B, SPORN M B. The transforming growth factor-βs. In: SPORN M B, ROBERTS A B, eds. Handbook of experimental pharmacology, Vol 95/1. Heidelberg: Springer-Verlag, 1990: 419-472.
2. MASSAGUÉ J. The transforming growth factor-β family. Annu Rev Cell Biol 1990: 6: 597-641.
3. LAIHO M, KESKI-OJA J. Transforming growth factors-β as regulators of cellular growth and phenotype. Crit Rev Oncog 1992: 3: 1-26.
4. FAUSTO N. Multifunctional roles for transforming growth factor-β1. Lab Invest 1991: 65: 497-499.
5. CASTILLA A, PRIETO J, FAUSTO N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991: 324: 933-940.
6. NAKATSUKASA H, EVARTS RP, HSIA C, THORGEIRSSON SS. Transforming growth factor-β1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 1990: 63: 171-180.
7. BRAUN L, MEAD JE, PANZICA M, MIKUMO R, BELL GI, FAUSTO N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988: 85: 1539-1543.
8. FAUSTO N, MEAD J E. Biology of disease. Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest 1989: 60: 4-13.
9. BRAUN L, GRUPPUSO P, MIKUMO R, FAUSTO N. Transforming growth factor β1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Differ 1989: 1: 103-111.
10. NAKATSUKASA H, EVARTS R P, HSIA C, MARSDEN E, THORGEIRSSON S S. Expression of transforming growth factor-β1 during chemical hepatocarcinogenesis in the rat. Lab Invest 1991: 65: 511-517.
11. ITO N, KAWATA S, TAMURA S, et al. Elevated levels of transforming growth factor-β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991: 51: 4080-4083.
12. WRIGHT J A, TURLEY E A, GREENBERG A H. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 1993: 4: 473-492.
13. SCHULTE-HERMANN R, BURSCH W, KRAUPP-GRASL B, OBERHAMMER F, WAGNER A, JIRTLE R. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ Health Perspect 1993: 101 (Suppl. 5): 87-90.
14. DERYNCK R, GOEDDEL D V, ULLRICH A, et al Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptors by human tumors. Cancer Res 1987: 47: 707-712.
15. JASANI B, WYLLIE F S, WRIGHT P A, LEMOINE N R, WILLIAMS, E D, WYNFORD-THOMAS D. Immunocytochemically detectable TGF-β associated with malignancy in thyroid epithelial neoplasia. Growth Factors 1990: 2: 149-155.
16. MCCUNE B K, MULLIN B R, FLANDERS K C, JAFFURS W J, MULLEN L T, SPORN M B. Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 1992: 23: 13-20.
17. JAKOWLEW S B, KONDAIAH P, FLANDERS K C, et al. Increased expression of growth factor mRNAs accompanies viral transformation of rodent cells. Oncogene Res 1988: 2: 135-148.
18. BERMAN M M, LIBBEY N P, FOSTER J H. Hepatocellular carcinoma, polygonal cell type with fibrous stroma. An atypical variant with a favorable prognosis. Cancer 1980: 6: 1448-1455.
19. CRAIG J R, PETERS R L, EDMONDSON H A, OMATA M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980: 46: 372-379.
20. ORSATTI G, GREENBERG P D, ROLFES D B, ISHAK K G, PARONETTO F. DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis. Hum Pathol 1994: 25: 936-939.
21. SWEAT F, PUCHTLER H, ROSENTHAL S I. Sirius red F3BA as a stain for connective tissue. Arch Pathol 1964: 78: 69-72.
22. CRAIG J R, PETERS R L, EDMONDSON H A. Tumors of the liver and intrahepatic bile ducts. AFIP Fascicle, 2nd Series, Washington, DC, 1989: 153-156.
23. ANZANO M A, ROBERTS A B, DE LARCO J E, et al. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol Cell Biol 1985: 5: 242-247.
24. BEDOSSA P, PELTIER E, TERRIS B, FRANCO D, POYNARD T. Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995: 21: 760-766.
25. GOMELLA L G, SARGENT E R, WADE T P, ANGLARD P, LINEHAN W M, KASID A. Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 1989: 49: 6972-6975
26. BARRETT-LEE P, TRAVERS M, LUQMANI Y, COOMBES R C. Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer 1990: 61: 612-617.
27. YOSHIDA K, YOKOZAKI H, NIIMOTO M, ITO H, ITO M, TAHARA E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int J Cancer 1989: 44: 394-398.